This is a preview of subscription content, log in via an institution to check access.
Reference
Vazquez Blanco S, et al. Alemtuzumab for relapsing-remitting multiple sclerosis: Effectiveness and safety. European Journal of Hospital Pharmacy - Science and Practice 27 (Suppl.): A177-A178 abstr. 5PSQ-061, Mar 2020. Available from: URL: http://doi.org/10.1136/ejhpharm-2020-eahpconf.378 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1829, 25 (2020). https://doi.org/10.1007/s40278-020-85615-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85615-6